業績

原著論文　2014年～2015年

  1. Narusawa M, Inoue H, Sakamoto C, Matsumura Y, Takahashi A, Inoue T, Watanabe A, Miyamoto S, Miura Y, Hijikata Y, Tanaka Y, Inoue M, Takayama K, Okazaki T, Hasegawa M, Nakanishi Y, Tani K. TLR7 Ligand Augments GM-CSF-Initiated Antitumor Immunity through Activation of Plasmacytoid Dendritic Cells. Cancer Immunol Res 2:568-580, 2014 [PubMed]
  2. Nii T, Marumoto T, Kawano H, Yamaguchi S, Liao J, Okada M, Sasaki E, Miura Y, Tani K. Analysis of essential pathways for self-renewal in common marmoset embryonic stem cells.FEBS Open Bio 4:213-9, 2014 [PubMed]
  3. Yamaguchi S, Marumoto T, Nii T, Kawano H, Liao J, Nagai Y, Okada M, Takahashi A, Inoue H, Sasaki E, Fujii H, Okano S, Ebise H, Sato T, Suyama M, Okano H, Miura Y, Tani K. Characterization of common marmoset dysgerminoma-like tumor induced by the lentiviral expression of reprogramming factors. Cancer Sci 105(4):402-8, 2014 [PubMed]
  4. Hamada, K., Shirakawa, T., Terao, S., Gotoh, A., Tani, K., Huang W. Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter.Mol Ther Methods Clin Dev 1:14019, 2014
  5. Kummalue T, Inoue T, Miura Y, Narusawa M, Inoue H, Komatsu N, Wanachiwanawin W, Sugiyama D, Tani K. Ribosomal protein L11- and retinol dehydrogenase 11-induced erythroid proliferation without erythropoietin in UT-7/Epo erythroleukemic cells. Exp Hematol43(5):414-423.e1, 2015 [PubMed]

原著論文　2012年～2013年

  1. Miyamoto S, Inoue H, Nakamura T, Yamada M, Sakamoto C, Urata Y, Okazaki T, Marumoto T, Takahashi A, Takayama K, Nakanishi Y, Shimizu H, Tani K. Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma. Cancer Res. 72(10):2609-2, 2012 [PubMed]
  2. Yokota Y, Inoue H, Matsumura Y, Nabeta H, Narusawa M, Watanabe A, Sakamoto C, Hijikata Y, Iga-Murahashi M, Takayama K, Sasaki F, Nakanishi Y, Yokomizo T, Tani K. Absence of LTB4/BLT1 axis facilitates generation of mouse GM-CSF-induced long-lasting antitumor immunologic memory by enhancing innate and adaptive immune systems. Blood120(17):3444-5, 2012 [PubMed]
  3. Somada S, Muta H, Nakamura K, Sun X, Honda K, Ihara E, Akiho H, Takayanagi R, Yoshikai Y, Podack ER, Tani K. CD30 Ligand/CD30 Interaction is involved in pathogenesis of inflammatory bowel disease. Dig Dis Sci. 57: 2031-2037, 2012[PubMed]
  4. Dong Y., Kobayashi S, Tian Y, Ozawa M, Hiramoto T, Izawa K, Bai Y, Soda Y, Sasaki E, Itoh T, Maru Y, Oyaizu N, Tojo A, Kai C, Tani K. Leukemogenic fusion gene (p190 BCR-ABL) transduction into hematopoietic stem/progenitor cells in the common marmoset. Open J Blood Dis. 2(1): 1-10 2012 [PDF]
  5. Hamada K, Yoshihara C, Ito T, Tani K, Tagawa M, Sakuragawa N, Itoh H, Koyama Y. Antitumor effect of chondroitin sulfate-coated ternary granulocyte macrophage colony- stimulating factor plasmid complex for ovarian cancer. J Gene Med. 14:5120-127, 2012.
  6. Mizuochi C, Fraser ST, Biasch K, Horio Y, Kikushige Y, Tani K, Akashi K, Tavian M, Sugiyama D. Intra-aortic clusters undergo endothelial to hematopoietic phenotypic changes in early embryogenesis. PLoS One 7(4):e35763, 2012
  7. Nunomura S, Shimada S, Kametani Y, Yamada Y, Yoshioka M, Suemizu H, Ozawa M, Itoh T, Kono A, Suzuki R, Tani K, Ando K, Yagita H, Ra C, Habu S, Satake M, Sasaki E. Double expression of CD34 and CD117 on bone marrow progenitors is a hallmark of the development of functional mast cell of Callithrix jacchus (common marmoset). Int Immunol. 24(9):593-603, 2012
  8. Hiramoto T, Ebihara Y, Mizoguchi Y, Nakamura K, Yamaguchi K, Ueno K, Nariai N, Mochizuki S, Yamamoto S, Nagasaki M, Furukawa Y, Tani K, Nakauchi H, Kobayashi M, Tsuji K. Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells. Proc Natl Acad Sci USA 110(8):3023-8, 2013[PubMed]
  9. Kobayashi S, Tian Y, Ohno N, Yuji K, Ishigaki T, Isobe M, Tsuda M, Oyaizu N, Watanabe E, Watanabe N, Tani K, Tojo A, Uchimaru K. The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-I. PLoS One8(1):e53728, 2013
  10. Liao J, Marumoto T, Yamaguchi S, Okano S, Takeda N, Sakamoto C, Kawano H, Nii T, Miyamoto S, Nagai Y, Okada M, Inoue H, Kawahara K, Suzuki A, Miura Y, Tani K. Inhibition of PTEN tumor suppressor promotes the generation of induced pluripotent stem cells. Mol Ther21(6):1242-50, 2013 [PubMed]
  11. Kurita R, Suda N, Sudo K, Miharada K, Hiroyama T, Miyoshi H, Tani K, Nakamura Y. Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells. PLoS One 8(3):e59890, 2013
  12. Chen MH, Soda Y, Izawa K, Kobayashi S, Tani K, Maruyama K, Tojo A, Asano S. A versatile drug delivery system using streptavidin-tagged pegylated liposomes and biotinylated biomaterials. Int J Pharm 454(1):478-8, 2013
  13. Ye F, Zhang Y, Liu Y, Yamada K, Tso JL, Menjivar JC, Tian JY, Yong WH, Schaue D, Mischel PS, Cloughesy TF, Nelson SF, Liau LM, McBride W, Tso CL. Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence. PLoS One 8(11):e80397, 2013

英文総説　2012～2013年

  1. Nii T, Marumoto T, Tani K. Roles of p53 in various biological aspects of hematopoietic stem cells. J Biomed Biotechnol 2012:903435, 2012 [PubMed]
  2. Inoue-Yokoo, T., Tani, K., Sugiyama, D. Mesodermal and hematopoietic differentiation from ES and iPS cells. Stem Cell Rev 9:422-434, 2013 [PubMed]
  3. Inoue, H., Tani, K. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments. Cell Death Differ 21:39-49, 2013[PubMed]

邦文総説　2014～2015年

  1. 成澤 慈、井上 博之．マイクロアレイ実験とその応用［研究手法入門：生化学・免疫学的実験法］呼吸，第33巻 第4号，374－380, 2014
  2. 高橋 淳、谷 憲三朗．再生医療．臍帯血移植の基礎と臨床（浅野 茂隆、谷口 克監修; 東條 有伸，谷 憲三朗，高橋 聡，幸道 秀樹編集）pp.243-260、医学書院、東京, 2014
  3. 谷 憲三朗．再生医療等の安全性の確保等に関する法律について、腫瘍内科 16巻　1号，66-82, 2015

邦文総説　2010～2013年

  1. 吉村清、岡　正朗、谷憲三朗、遺伝子診療学-遺伝子診断の進歩とゲノム治療の展望-、68：451-457, 2010
  2. 谷憲三朗、悪性腫瘍に対する免疫遺伝子・細胞療法の現状と展望、臨床血液 51:296-302, 2010
  3. 村橋（伊賀）睦了、土方康基、末廣陽子、田中芳浩、下田真也、丸本朋稔、岡崎利彦、吉田浩二、角田卓也、谷憲三朗、抗腫瘍免疫療法における新戦略-New strategies of immunetherapy targeting malignancy-、臨床血液、51：1654-60, 2010
  4. 井上博之、谷憲三朗、サイトカインと癌治療、臨床検査 54：670-676, 2010
  5. 谷憲三朗、悪性腫瘍に対する免疫遺伝子・細胞療法の現状と今後の課題、胆と膵、32：107～116，2011
  6. Hijikata Y, Murahashi-Iga M, Okazaki T, Tanaka Y, Odaira K, Okano S, Hisano T, Takahashi A, Marumoto T, Inoue H, Tani K. [Development of novel immune therapies for solid tumors: phase I clinical trials in a single institute]. RinshoKetsueki 53(5):487-92, 2012 [PubMed]
  7. 横田　洋介、井上　博之、谷　憲三朗. Trends in Hematological Malignancies. LTB4/BLT1 シグナル伝達欠失は免疫機構を増強することで長期的抗腫瘍免疫記憶を促進する 2013年6月30日発行（第5巻　第2号）p16-19 メディカルレビュー社, 2013
  8. 井上　博之、高山　浩一、中西　洋一. 癌ワクチン療法（Cancer vaccine therapy）日本臨床　最新肺癌学（基礎と臨床の最新研究動向）71巻　増刊号6 p242－247, 2013
  9. 野崎　要、井上　博之、高山　浩一、中西　洋一、谷　憲三朗. 遺伝子治療（Gene therapy）日本臨床　最新肺癌学（基礎と臨床の最新研究動向）71巻　増刊号6 p276－281, 2013

学会発表　2014～2015年

  1. Takenobu Nii, Tomotoshi Marumoto, Saori Yamaguchi, Jiyuan Liao, Kenzaburo Tani Improved Hematopoietic Differentiation of Primate Embryonic Stem Cells. The 56th American Society of Hematology (ASH) Annual Meeting, San Francisco, CA, USA, 2014
  2. Megumi Narusawa, Hiroyuki Inoue, Chika Sakamoto, Yumiko Matsumura, Koichi Takayama, Yoichi Nakanishi and Kenzaburo Tani. The role of plasmacytoid dendritic cells in GM-CSF-based antitumor immunity. The 24th Hot Spring Harbor International Symposium, Fukuoka, 2014
  3. Shohei Miyamoto, Hiroyuki Inoue, Miyako Sagara, Misato Kai, Masaki Kuroda, Hiroyuki Shimizu, Yoichi Nakanishi, and Kenzaburo Tani. MicroRNA-targeted coxsackievirus B3 abrogates its pathogenicity retaining oncolytic activity. The 24th Hot Spring Harbor International Symposium, Fukuoka, 2014
  4. Hiroyuki Inoue, Yuki Nakano, Beibei Wang, Shohei Miyamoto, Megumi Narusawa, Chika Sakamoto, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. Coxsackievirus A11 possesses extensive oncolytic activity against human non-small cell lung cancer cells. The 17th Annual Meeting of American Society of Gene and Cell Therapy. Washington DC, USA, 2014
  5. Beibei Wang, Hiroyuki Inoue, Shohei Miyamoto, Yuki Nakano, Chika Sakamoto, Megumi Narusawa, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. Coxsackievirus A11 displays remarkable oncolytic activity against oxaliplatin-resistant human colorectal cancer cells. The 17th Annual Meeting of American Society of Gene and Cell Therapy. Washington DC, 2014
  6. Miyako Sagara, Misato Kai, Hiroyuki Inoue, Shohei Miyamoto, Yuto Takishima, Kyosuke Kobayashi , Yuki Nakano, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. Coxsackievirus B3 exhibits potent oncolytic activity against both human malignant pleural mesothelioma and triple-negative breast cancer cells. The 17th Annual Meeting of American Society of Gene and Cell Therapy. Washington DC, USA, 2014
  7. Chika Sakamoto, Hiroyuki Inoue, Megumi Narusawa, Yumiko Matsumura, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, and Kenzaburo Tani. Therapeutic vaccination with irradiated GM-CSF gene-transduced cancer side population cells effectively suppress tumor growth and lung metastasis. The 17th Annual Meeting of American Society of Gene and Cell Therapy. Washington DC, USA, 2014
  8. Hiroyuki Inoue, Ayumi Watanabe, Megumi Narusawa, Chika Sakamoto, Takafumi Hiramoto, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, Tomoki Todo and Kenzaburo Tani. Therapeutic vaccination with GM-CSF gene-transduced iPS cells induces potent T cells-mediated antitumor immunity. The 105th Annual Meeting of American Association of Cancer Research, San Diego, CA, USA, 2014
  9. Yasuki Hijikata, Hiroyuki Inoue, Mutsunori Murahashi, Shinji Okano, Yoshihiro Tanaka, Atsushi Takahashi, Toshihiko Okazaki, Yoichi Nakanishi, Koji Yoshida, Takuya Tsunoda, Yusuke Nakamura, Kenzaburo Tani. A phase I clinical trial of RNF43 peptide-specific immune cell therapy combined with low-dose cyclophosphamide for patients with advanced solid tumors. The 105th Annual Meeting of American Association of Cancer Research, San Diego, CA, USA, 2014
  10. Y. Li, K. Kobayashi, M. M. Mona, C. Satomi, K. Tani, A. Takahashi. FEAT inhibits cell death by modifying intracellular localization of apoptotic signaling factors. Gordon Research Conference on Cell Death, West Dover, VT, USA, 2014
  11. Y. Li, K. Kobayashi, M.M. Mona, C. Satomi, K. Tani, A. Takahashi. Biochemical and intracellular functions of antiapoptotic FEAT protein. Cell Symposia: Hallmarks of Cancer: Asia, Beijing, China, 2014
  12. Megumi Narusawa, Hiroyuki Inoue, Chika Sakamoto, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi and Kenzaburo Tani. Plasmacytoid dendritic cells play an essential role in induction of GM-CSF-based antitumor immunity. 第76回日本血液学会学術集会，大阪, 2014
  13. Chika Sakamoto, Hiroyuki Inoue, Megumi Narusawa, Yumiko Matsumura, Kazunari Yamada, Takafumi Hiramoto, Atsushi Takahashi, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, and Kenzaburo Tani. Therapeutic tumor vaccination with GM-CSF gene-transduced cancer stem cells provokes potent antitumor immunity. 第76回日本血液学会学術集会，大阪, 2014
  14. Takenobu Nii, Tomotoshi Marumoto, Saori Yamaguchi, Jiyuan Liao, Kazunari Yamada, Yasuki Hijikata, Toshiyuki Tsuruta and Kenzaburo Tani. Improved hematopoietic differentiation of primate ESCs by inhibition of PI3K-AKT pathway. 第76回日本血液学会学術集会, 大阪, 2014
  15. Hiroyuki Inoue, Yuki Nakano, Beibei Wang, Megumi Narusawa, Shohei Miyamoto, Chika Sakamoto, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. Coxsackievirus A11 exhibits ICAM-1-mediated oncolysis against human non-small cell lung cancer cells. 第73回日本癌学会学術総会，横浜, 2014
  16. Yasuki Hijikata, Toshihiko Okazaki, Kazunari Yamada, Koji Yoshida, Hiroyuki Inoue, Sonoko Ishihara, Kenzaburo Tani. A Phase I Clinical Trial of Immune Cell Therapy Combined with Cyclophosphamide for Patients with Advanced Solid Tumors. 第73回日本癌学会学術総会，横浜, 2014
  17. Beibei Wang, Hiroyuki Inoue, Shohei Miyamoto, Yuki Nakano, Chika Sakamoto, Megumi Narusawa, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. Coxsackievirus A11 is a promising oncolytic virus agent against oxaliplatin-resistant human colorectal cancer cells. 第73回日本癌学会学術総会，横浜, 2014
  18. Miyako Sagara, Misato Kai, Shohei Miyamoto, Hiroyuki Inoue, Yuto Takishima, Kyosuke Kobayashi, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. Coxsackievirus B3 confers robust oncolytic activity in malignant pleural mesothelioma and triple-negative breast cancer. 第73回日本癌学会学術総会，横浜, 2014
  19. Megumi Narusawa, Hiroyuki Inoue, Chika Sakamoto, Yumiko Matsumura, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi and Kenzaburo Tani. A role of plasmacytoid DCs in GM-CSF-induced antitumor immunity. 第6回血液疾患免疫療法研究会学術集会，京都, 2014
  20. Hiroyuki Inoue, Yuki Nakano, Beibei Wang, Shohei Miyamoto, Megumi Narusawa, Chika Sakamoto, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. Coxsackievirus A11 displays remarkable oncolytic activity against human non-small cell lung cancer cells. 第20回日本遺伝子治療学会学術集会，東京, 2014
  21. Chika Sakamoto, Hiroyuki Inoue, Megumi Narusawa, Yumiko Matsumura, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, and Kenzaburo Tani. Therapeutic vaccination with irradiated GM-CSF gene transduced cancer stem cells induces potent antitumor immunity in mice. 第20回日本遺伝子治療学会学術集会，東京, 2014
  22. Beibei Wang, Hiroyuki Inoue, Shohei Miyamoto, Yuki Nakano, Chika Sakamoto, Megumi Narusawa, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. Oncolytic virotherapy for oxaliplatin-resistant colorectal cancer cells using coxsackievirus A11. 第20回日本遺伝子治療学会学術集会，東京, 2014
  23. Miyako Sagara, Hiroyuki Inoue, Shohei Miyamoto, Misato Kai, Yuto Takishima, Kyosuke Kobayashi, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. Coxsackievirus B3 displays remarkable oncolytic activity against both malignant pleural mesothelioma and triple-negative breast cancer cells. 第20回日本遺伝子治療学会学術集会，東京, 2014
  24. Takenobu Nii, Tomotoshi Marumoto, Saori Yamaguchi, Hirotaka Kawano, Jiyuan Liao, Kenzaburo Tani. Improved hematopoietic differentiation of common marmoset embryonic stem cell. 第12回幹細胞シンポジウム, 福岡, 2014
  25. Hiroyuki Inoue, Ayumi Watanabe, Chika Sakamoto, Megumi Narusawa, Shohei Miyamoto, Koichi Takayama, Takafumi Hiramoto, Yoichi Nakanishi, and Kenzaburo Tani. Therapeutic vaccination using irradiated iPS cells induces potent antitumor immunity against poorly immunogenic lung tumors.第54回日本呼吸器学会学術講演会，大阪, 2014
  26. Yasuki Hijikata, Toshihiko Okazaki, Yoshihiro Tanaka, Kazunari Yamada and Kenzaburo Tani. A phase 1 clinical trial of RNF43 peptide-specific immune cell therapy combined with low dose cyclophosphamide for patients of advanced solid tumors. 第6回血液疾患免疫療法研究会学術集会，京都, 2014
  27. 山口沙織，丸本朋稔，二井偉暢，河野紘隆，寥紀元，永井陽子，岡田美智代，高橋淳，井上博之，佐々木えりか，藤井浩，岡野慎士，海老瀬速雄，佐藤哲也，須山幹太，岡野栄之，三浦由恵，谷憲三朗．初期化因子搭載レンチウイルスベクターにより誘導された未分化胚細胞腫様コモンマーモセット腫瘍の特性．第4回日本マーモセット研究会大会，愛知, 2015
  28. Takenobu Nii, Tomotoshi Marumoto, Saori Yamaguchi, Hirotaka Kawano, Jiyuan Liao, Erika Sasaki and Kenzaburo Tani. Transient inhibition of PI3K-AKT pathway promotes hematopoietic differentiation in common marmoset embryonic stem cells.第4回日本マーモセット研究会, 愛知, 2015
  29. Y. Li, K. Kobayashi, C. Satomi, K. Tani, A. Takahashi: Biochemical and intracellular function of FEAT protein. 第74回日本癌学会学術総会, 名古屋, 2015
  30. C. Satomi, M.M. Mona, K. Kobayashi, Y. Li, K. Tani, A. Takahashi: Regulation of human FEAT gene promoter. 第74回日本癌学会学術総会, 名古屋, 2015

学会発表　2012～2013年

  1. Hiroyuki Inoue, Yasuki Hijikata, Keisuke Yasunari, Akira Sakamoto, Shohei Miyamoto, Kaname Nosaki, Yumiko Matsumura, Koichi Takayama, Yoichi Nakanishi, and Kenzaburo Tani. Genetically engineered oncolytic Edmonston strain of measles virus harboring the wild-type N, P, L Genes (MV-NPL) effectively target lung cancer stem cells. American Association of Cancer Research, 103th Annual Meeting, Chicago, 2012
  2. Shohei Miyamoto, Hiroyuki Inoue, Beibei Wang, Keisuke Yasunari, Takafumi Nakamura, Meiko Yamada, Yasuo Urata, Tomotoshi Marumoto, Atsushi Takahashi, Koichi Takayama, Yoichi Nakanishi, Hiroyuki Shimizu and Kenzaburo Tani. Coxsackievirus B3 is an immunostimulatory oncolytic virus active against lung adenocarcinoma. American Association of Cancer Research, 103th Annual Meeting, Chicago, 2012
  3. Keisuke Yasunari, Hiroyuki Inoue, Shohei Miyamoto, Beibei Wang, Yasuo Urata, Koichi Takayama, Yoichi Nakanishi and Kenzaburo Tani. Oncolytic Echovirus 4 as a potent virotherapy agent against human esophageal squamous cell carcinoma. American Society of Gene and Cell Therapy, 15th Annual Meeting, Philadelphia, 2012
  4. Hiroyuki Inoue, Keisuke Yasunari, Akira Sakamoto, Shohei Miyamoto, Kaname Nosaki, Yumiko Matsumura, Takafumi Nakamura, Koichi Takayama, Yoichi Nakanishi, and Kenzaburo Tani. Genetically engineered Measles virus Edmonston strain expressing the wild-type N, P, L Genes (MV-NPL) is a promising oncolytic virotherapy agent against lung cancer stem cells. American Society of Gene and Cell Therapy, 15th Annual Meeting, Philadelphia, 2012
  5. Hiroyuki Inoue, Keisuke Yasunari, Yumiko Matsumura, Shohei Miyamoto, Kaname Nosaki, Akira Sakamoto, Koichi Takayama, Yoichi Nakanishi, and Kenzaburo Tani. Genetically engineered oncolytic measles virus lyses non-small cell lung cancer stem cells in vitro and in vivo. Asian Pacific Lung Cancer Conference, 5th Annual Meeting, Fukuoka, 2012
  6. Hiroyuki Inoue, Keisuke Yasunari, Yumiko Matsumura, Shohei Miyamoto, Akira Sakamoto, Kaname Nosaki, Koichi Takayama, Yoichi Nakanishi, and Kenzaburo Tani. Genetically engineered oncolytic measles virus effectively targets and kills non-small cell lung cancer stem cells. Asian Pacific Society of Respirology, 17th Annual Meeting, Hong Kong, 2012
  7. Saori Yamaguchi, Tomotoshi Marumoto,, Takenobu Nii, Hirotaka Kawano, Jiyuan Liao, Yoko Nagai, Michiko Okada, Atsushi Takahashi, Hiroyuki Inoue, Erika Sasaki, Shinji Okano, Yoshie Miura, Kenzaburo Tani. Chracterization of dysgerminoma like tumors arose in the process of generating common marmoset induced pluripotent stem cells. International Society for Stem Cell Research (ISSCR), 10th Annual Meeting, Yokohama, 2012
  8. Takenobu Nii, Tomotoshi Marumoto, Hirotaka Kawano, Saori Yamaguchi, Yoko Nagai, Yoshie Miura, Jiyuan Liao, Michiyo Okada, Kenzaburo Tani. Efficient hematopoietic differentiation of common marmoset embryonic stem cells by the inhibition of PI3K-AKT pathway. International Society for Stem Cell Research (ISSCR), 10th Annual Meeting, Yokohama, 2012
  9. Jiyuan Liao, Tomotoshi Marumoto, Saori Yamaguchi, Shinji Okano, Naoki Takeda, Chika Sakamoto, Hirotaka Kawano, Takenobu Nii, Yoko Nagai, Michiyo Okada, Yoshie Miura, PhD1, Shinya Shimoda, Hiroyuki Inoue, Atsushi Takahashi, Masato Tanaka, Kaori Nagatoshi, Ken-ichi Yamamura, Kohichi Kawahara, Akira Suzuki, and Kenzaburo Tani. Efficient generation of induced pluripotent stem cells by the use of Pten inhibitor. International Society for Stem Cell Research (ISSCR), 10th Annual Meeting, Yokohama, 2012
  10. Kobayashi K, Li Y, Kawahara K, Suzuki A, Tani K, Takahashi A. Characterization of FEAT functions in vivo. Gordon Research Conference on Cell Death, Lucca (Barga), Italy, 2012
  11. Jiyuan Liao, Tomotoshi Marumoto, Saori Yamaguchi, Shinji Okano, Yoshie Miura, Hiroyuki Inoue, Masato Tanaka, Kaori Nagatoshi, Kohichi Kawahara, Akira Suzuki, Kenzaburo Tani, Efficient generation of induced pluripotent stem cells by the inhibition of PTEN tumor suppressor. The 21st Hot Spring Harbor Symposium jointly with 9th Global COE International Symposium. Cell Migration in Biology and Medicine, Fukuoka, 2012
  12. Murahashi M, Hijikata Y, Tanaka Y, Inoue H, Marumoto T, Nakanishi Y, Yoshida K, Tsunoda Nakamura, Y, Tani K. Phase I clinical trial of cancer vaccine combined with chemotherapy targeting both tumor antigen and immune tolerance against advanced solid tumors. 37th ESMO Congress, Vienna, Austria, 2012
  13. Yosuke Yokota, Hiroyuki Inoue, Ayumi Watanabe, Chika Sakamoto, Megumi Narusawa, Shohei Miyamoto, Koichi Takayama, Yoichi Nakanishi ,Takehiko Yokomizo and Kenzaburo Tani. Absence of LTB4/BLT1 axis promotes generation of long-lasting antitumor memory responses induced by administration of GM-CSF gene-transduced tumor cells, in a CD4+ T cell-dependent manner. American Society of Hematology, 54th Annual Meeting, San Diego, 2012
  14. Jiyuan Liao, Tomotoshi Marumoto, Shinji Okano, Saori Yamaguchi, Takenobu Nii, Hirotaka Kawano, Yoko Nagai, Chika Sakamoto, Michiyo Okada, Yoshie Miura, Hiroyuki Inoue, Masato Tanaka, Kaori Nagatoshi, Kohichi Kawahara, Akira Suzuki and Kenzaburo Tani, Inhibition of PTEN tumor suppressor promotes the generation of induced pluripotent stem cells. American Society of Hematology, 54th Annual Meeting, San Diego, 2012
  15. Hiroyuki Inoue, Shohei Miyamoto, Takafumi Nakamura, Meiko Yamada, Yasuo Urata, Koichi Takayama, Yoichi Nakanishi, Hiroyuki Shimizu and Kenzaburo Tani. Coxsackievirus B3 (CVB3) as a Novel Oncolytic Virotherapy Agent against Non Small Cell Lung Cancer. 第52回日本肺癌学会総会, 大阪, 2012
  16. Hiroyuki Inoue, Shohei Miyamoto, Meiko Yamada, Takafumi Nakamura, Nosaki Kaname, Urata Yasuo, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. Coxsackievirus B3 is an Oncolytic Virus Active Against Non-Small Cell Lung Cancer. 第52回日本呼吸器学会学術講演会, 神戸, 2012
  17. Hiroyuki Inoue, Akira Sakamoto, Keisuke Yasunari, Shohei Miyamoto, Yumiko Matsumura, Kaname Nosaki, Koichi Takayama, Yoichi Nakanishi, and Kenzaburo Tani. Novel engineered oncolytic Edmonston strain of measles virus elicits remarkable oncolytic activity against non-small cell lung cancer stem cells. 第18回日本遺伝子治療学会, 熊本, 2012
  18. Shohei Miyamoto, Hiroyuki Inoue, Beibei Wang, Chika Sakamoto, Megumi Narusawa, Takafumi Nakamura, Meiko Yamada, Yasuo Urata, Koichi Takayama, Yoichi Nakanishi, Hiroyuki Shimizu and Kenzaburo Tani. Coxsackievirus B3 is an immunostimulatoryoncolytic virus active against lung adenocarcinoma. 第18回日本遺伝子治療学会, 熊本, 2012
  19. Saori Yamaguchi, Tomotoshi Marumoto, Takenobu Nii, Hirotaka Kawano, Jiyuan Liao, Yoko Nagai, Michiyo Okada, Atsushi Takahashi, Hiroyuki Inoue, Erika Sasaki, Shinji Okano, Yoshie Miura and Kenzaburo Tani. Characterization of common marmoset dysgerminoma-like tumors generated by the transduction of reprogramming factors. 第18回日本遺伝子治療学会, 熊本, 2012
  20. Takenobu Nii, Tomotoshi Marumoto, Hirotaka Kawano, Saori Yamaguchi, Yoko Nagai, Yoshie Miura, Jiyuan Liao, Michiyo Okada, Kenzaburo Tani. Efficient hematopoietic differentiation of common marmoset embryonic stem cells by the inhibition of PI3K-AKT pathway. 第18回日本遺伝子治療学会, 熊本, 2012
  21. Jiyuan Liao, Tomotoshi Marumoto, Saori Yamaguchi, Shinji Okano, Naoki Takeda, Chika Sakamoto, Hirotaka Kawano, Takenobu Nii, Yoko Nagai, Michiyo Okada, Yoshie Miura, Shinya Shimoda, Hiroyuki Inoue, Atsushi Takahashi, Masato Tanaka, Kaori Nagatoshi, Ken-ichi Yamamura, Kohichi Kawahara, Akira Suzuki and Kenzaburo Tani. Highly efficient generation of induced pluripotent stem cells by the inhibition of PTEN tumor suppressor. 第18回日本遺伝子治療学会, 熊本, 2012
  22. Jiyuan Liao, Tomotoshi Marumoto, Saori Yamaguchi, Shinji Okano, Hirotaka Kawano, Takenobu Nii, Yoko Nagai, Chika Sakamoto, Michiyo Okada, Yoshie Miura, Hiroyuki Inoue, Masato Tanaka, Kaori Nagatoshi, Kohichi Kawahara, Akira Suzuki and Kenzaburo Tani. Inhibition of PTEN tumor suppressor promotes the generation of induced pluripotent stem cells. 九州大学グローバルCOE・生体防御医学研究所　国際シンポジウム若手発表会, 福岡, 2012
  23. Hiroyuki Inoue, Shohei Miyamoto, Beibei Wang, Keisuke Yasunari, Meiko Yamada, Yasuo Urata, Koichi Takayama, Yoichi Nakanishi, Hiroyuki Shimizu and Kenzaburo Tani. 非小細胞肺癌に対するコクサッキーウイルスB3を用いた新規腫瘍溶解性ウイルス療法, 第28回日本DDS学会学術集会, 札幌, 2012
  24. Megumi Narusawa, Hiroyuki Inoue, Chika Sakamoto, Yosuke Yokota, Ayumi Watanabe, Shohei Miyamoto, Koichi Takayama, Makoto Inoue, Mamoru Hasegawa, Yoichi Nakanishi and Kenzaburo Tani. TLR7 ligand Imiquimod enhances GM-CSF-induced immunological antitumor effect. 第4回造血器腫瘍免疫療法研究会学術集会, 金沢, 2012
  25. 土方 康基, 岡崎 利彦, 田中 芳浩, 小林 慎一, 村橋 睦了, 山田 一成, 丸本 朋稔, 井上 博之, 谷 憲三朗, A phase I study of adoptive immunotherapy using autologous dendritic cell pulsed with a RNF43 peptide in patients with advanced solid tumors. 第4回造血器腫瘍免疫療法研究会学術集会, 金沢, 2012
  26. 村橋 睦了, 土方 康基, 田中 芳浩, 岸本 淳司, 井上 博之, 丸本 朋稔, 高橋 淳, 岡崎 利彦, 平川 雅和, 岡野 慎士, 谷 憲三朗, Multipeptide immune responses to cancer vaccine after cyclophosphamide correlated with longer survival of the patients with advanced solid tumors, 第4回造血器腫瘍免疫療法研究会学術集会, 金沢, 2012
  27. 宮原　裕, 村橋睦了, 山田一成, 土方康基, 井上博之, 丸本朋稔, 松田めぐみ,谷　憲三朗, 塩化ナトリウム内服で改善した中枢性塩類喪失症候群（Cerebral Salt Wasting Syndrome: CSWS）の1例, 第300回日本内科学会九州地方会, 福岡, 2012
  28. Ayumi Wanatabe, Hiroyuki Inoue, Chika Sakamoto, Megumi Narusawa, Shohei Miyamoto, Makoto Inoue, Keisuke Okita, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, Shinya Yamanaka　and Kenzaburo Tani.　Novel cancer immunotherapy using induced pluripotent stem cells genetically engineered to produce GM-CSF. 第71回日本癌学会学術総会, 札幌, 2012
  29. Megumi Narusawa, Hiroyuki Inoue, Chika Sakamoto, Ayumi Watanabe, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi　and Kenzaburo Tani. Plasmacytoid DCs are involved in an antitumor immunity induced by GM-CSF gene-transduced tumor cells. 第71回日本癌学会学術総会, 札幌, 2012
  30. Hiroyuki Inoue, Keisuke Yasunari, Shohei Miyamoto, Yumiko Matsumura, Kaname Nosaki, Akira Sakamoto, Koichi Takayama, Yoichi Nakanishi　and Kenzaburo Tani.　Novel engineered oncolytic measles virus shows oncolytic acticity against non-small cell lung cancer stem cells. 第71回日本癌学会学術総会, 札幌, 2012
  31. Shohei Miyamoto, Hiroyuki Inoue, Beibei Wang, Keisuke Yasunari, Chika Sakamoto, Megumi Narusawa, Takafumi Nakamura, Meiko Yamada ,Yasuo Urata, Koichi Takayama, Yoichi Nakanishi, Hiroyuki Shimizu and Kenzaburo Tani. Immunostimulatory coxsackievirus B3 as a potent oncolytic agent against non-small cell lung carcinoma. 第71回日本癌学会学術総会, 札幌, 2012
  32. Kobayashi K, Kawahara K, Suzuki A, Tani K, Takahashi A. Characterization of FEAT functions in vivo. 第71回日本癌学会学術総会, 札幌, 2012
  33. 土方康基, 岡崎利彦, 田中芳浩, 大平公亮, 小林慎一, 村橋睦了, 高橋淳, 丸本朋稔, 井上博之, 吉田浩二, 角田卓也, 谷憲三朗, 進行固形腫瘍患者に対する化学療法併用新規免疫細胞療法臨床研究,第50回日本癌治療学会学術集会, 横浜, 2012
  34. Hiroyuki Inoue, Ayumi Watanabe, Chika Sakamoto, Megumi Narusawa, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, and Kenzaburo Tani. A novel cancer cell vaccine using induced pluripotent stem cells genetically engineered to produce GM-CSF elicits substantial antitumor immunity in a syngeneic mouse model. The 16th Annual Meeting of American Society of Gene and Cell Therapy. Salt Lake City, UT, May 15-18, 2013
  35. Shohei Miyamoto, Hiroyuki Inoue, Miyako Sagara, Beibei Wang, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. Dual microRNA-regulated oncolytic coxsackievirus B3 infection displays antitumor activity with attenuated pathogenicity in mice. The 16th Annual Meeting of American Society of Gene and Cell Therapy. Salt Lake City, UT, May 15-18, 2013
  36. Takafumi Hiramoto, Yasuhiro Ebihara Yoko Mizoguchi, Kazuhiro Nakamura, Kiyoshi Yamaguchi, Kazuko Ueno, Shinji Mochizuki, Naoki Nariai, Shohei Yamamoto, Masao Nagasaki, Yoichi Furukawa, Kenzaburo Tani, Hiromitsu Nakauchi, Masao Kobayashi, and Koichiro Tsuji. The activation of the Wnt3a/β-catenin pathway induced maturation of impaired neutrophils as well as the endoplasmic reticulum stress in induced pluripotent stem cell derived from a Severe Congenital Neutropenia patient with ELANE mutation. The 16th Annual Meeting of American Society of Gene and Cell Therapy. Salt Lake City, UT, May 15-18, 2013
  37. Megumi Narusawa, Hiroyuki Inoue, Chika Sakamoto, Tomoko Inoue, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, and Kenzaburo Tani. Combination use of TLR7 ligand with GM-CSF gene-transduced tumor vaccines provides substantial antitumor immunity against poorly immunogenic mouse lung cancer cells. The 16th Annual Meeting of American Society of Gene and Cell Therapy. Salt Lake City, UT, May 15-18, 2013
  38. Miyako Sagara, Hiroyuki Inoue, Shohei Miyamoto, Chika Sakamoto, Yuki Nakano, Koichi Takayama, Hiroyuki Shimizu Yoichi Nakanishi and Kenzaburo Tani. CVB3 infection elicits potent oncolytic activity against lung cancer stem cells. The 16th Annual Meeting of American Society of Gene and Cell Therapy. Salt Lake City, UT, May 15-18, 2013
  39. Megumi Narusawa, Hiroyuki Inoue, Chika Sakamoto, Tomoko Inoue, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, Kenzaburo Tani. Gene expression profiling identifies plasmacytoid dendritic cells as positive regulators in GM-CSF-induced antitumor immunity. The 4th Japanese Society of Hematology International Symposium 2013, Matsuyama, Japan, May 24-25, 2013
  40. Takenobu Nii, Tomotoshi Marumoto, Saori Yamaguchi, Hirotaka Kawano, Jiyuan Liao, Yoko Nagai, Michiyo Okada, Yoshie Miura, Kenzaburo Tani: Efficient hematopoietic differentiation of common marmoset embryonic stem cells by the inhibition of their self-renewal pathway. International Society for Stem Cell Research (ISSCR), Boston, MA, June 12-15, 2013
  41. Chika Sakamoto, Hiroyuki Inoue, Megumi Narusawa, Shohei Miyamoto, and Kenzaburo Tani. Therapeutic vaccine with GM-CSF gene-transduced cancer stem cells inhibits tumor growth and metastasis of breast cancer. The 23rd Hot Spring Harbor International Symposium, Recent Advances in Stem Cell Biology 2013. Fukuoka, Japan, November 4-6, 2013
  42. Shohei Miyamoto, Hiroyuki Inoue, Miyako Sagara, Beibei Wang, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi, Kenzaburo Tani. MicroRNA-regulated coxsackievirus B3 abrogates its pathogenicity retaining oncolytic activity. The 23rd Hot Spring Harbor International Symposium, Recent Advances in Stem Cell Biology 2013. Fukuoka, Japan, November 4-6, 2013
  43. Shohei Miyamoto, Hiroyuki Inoue, Miyako Sagara, Beibei Wang, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi, Kenzaburo Tani. MicroRNA-targeted coxsackievirus B3 infection markedly reduces its toxicity without losing its original oncolytic activity. Therapeutics Discovery Symposium Asia Small RNAs to Stem Cells & Epigenetic Reprogramming Asia-2013 Meeting On ‘RNA Regulation to Delivery, Programming to Pluripotency & Therapeutics’. Tokyo, Japan, November 25-26, 2013
  44. Hiroyuki Inoue, Ayumi Watanabe, Chika Sakamoto, Megumi Narusawa, Takafumi Hiramoto, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, and Kenzaburo Tani. Vaccination with irradiated induced pluripotent stem cells genetically engineered to produce GM-CSF confers potent T cells-mediated antitumor immunity. The 55th ASH Annual Meeting and Exposition. New Orleans, LA, December 7-10, 2013
  45. Megumi Narusawa, Hiroyuki Inoue, Chika Sakamoto, Yumiko Matsumura, Atsushi Takahashi, Ayumi Watanabe, Tomoko Inoue, Shohei Miyamoto, Koichi Takayama, Makoto Inoue, Mamoru Hasegawa, Yoichi Nakanishi and Kenzaburo Tani. TLR7 ligand potentiates GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells. The 55th ASH Annual Meeting and Exposition. New Orleans, LA, December 7-10, 2013
  46. Hirotaka Kawano, Tomotoshi Marumoto, Takafumi Hiramoto, Michiyo Okada, Tomoko Inoue, Takenobu Nii, Jiyuan Liao, Saori Yamaguchi, Hiroyuki Inoue, Erika Sasaki, Yoshie Miura, Kenzaburo Tani. Induced hematopoietic differentiation of Common Marmoset Embryonic Stem Cells by LYL1 can give rise to Hematopoietic Stem Cells having the Enhanced Bone Marrow Reconstitution capability. The 55th ASH Annual Meeting and Exposition. New Orleans, LA, December 7-10, 2013
  47. Hiroyuki Inoue, Keisuke Yasunari, Yumiko Matsumura, Kaname Nosaki, Shohei Miyamoto, Koichi Takayama, Yoichi Nakanishi, and Kenzaburo Tani. 肺癌幹細胞を標的とした新規遺伝子改変麻疹腫瘍溶解性ウイルス療法. 第53回日本呼吸器学会学術講演会, 東京, 2013
  48. Hiroyuki Inoue, Ayumi Watanabe, Chika Sakamoto, Megumi Narusawa, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, and Kenzaburo Tani. Vaccination with irradiated induced pluripotent stem cells genetically engineered to secrete GM-CSF provides substantial antitumor immunity in immunocompetent syngeneic mouse models. 第19回日本遺伝子治療学会, 岡山, 2013
  49. Megumi Narusawa, Hiroyuki Inoue, Chika Sakamoto, Tomoko Inoue, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, Kenzaburo Tani. Plasmacytoid dendritic cells play an essential role in GM-CSF-induced antitumor immunity. 第19回日本遺伝子治療学会, 岡山, 2013
  50. Miyako Sagara, Hiroyuki Inoue, Shohei Miyamoto, Chika Sakamoto, Yuki Nakano, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. Differential susceptibility of cancer stem cells and cancer cells undergoing epithelial-mesenchymal transition to oncolysis by CVB3 infection. 第19回日本遺伝子治療学会, 岡山, 2013
  51. Shohei Miyamoto, Hiroyuki Inoue, Miyako Sagara, Beibei Wang, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi, and Kenzaburo Tani. Infection with dual microRNA-targeted coxsackievirus B3 abrogates its pathogenicity retaining oncolytic activity. 第19回日本遺伝子治療学会, 岡山, 2013
  52. Hiroyuki Inoue, Keisuke Yasunari, Beibei Wang, Shohei Miyamoto, Koichi Takayama, Yoichi Nakanishi and Kenzaburo Tani. Infection with Echovirus?4 elicits potent oncolytic activity against cisplatin-resistant esophageal carcinoma. 第72回日本癌学会学術総会, 横浜, 2013
  53. Miyako Sagara, Hiroyuki Inoue, Shohei Miyamoto, Chika Sakamoto, Yuki Nakano, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. CVB3 infection displays different oncolytic activities against cancer stem cells and cancer cells undergoing EMT. 第72回日本癌学会学術総会, 横浜, 2013
  54. Chika Sakamoto, Hiroyuki Inoue, Megumi Narusawa, Shohei Miyamoto, Tomotoshi Marumoto, Atsushi Takahashi, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, and Kenzaburo Tani. Therapeutic vaccine with GM-CSF gene-transduced cancer stem cells inhibits tumor growth and metastasis of breast cancer. 第72回日本癌学会学術総会, 横浜, 2013
  55. Shohei Miyamoto, Hiroyuki Inoue, Miyako Sagara, Beibei Wang, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi and Kenzaburo Tani. MicroRNA-targeted coxsackievirus B3 infection markedly reduces its pathogenicity retaining oncolytic activity. 第72回日本癌学会学術総会, 横浜, 2013
  56. Toshihisa Tsuruta, Yasuo Aihara, Kazunari Yamada, Hiroyuki Inoue, Yasuki Hijikata, Tomotoshi Marumoto, Yoshikazu Okada, Kenzaburo Tani. Akt gene activation via VEGFR as a prognostic factor of pediatric low-grade glioma. 第72回日本癌学会学術総会, 横浜, 2013
  57. Yasuki Hijikata, Toshihiko Okazaki, Tomotoshi Marumoto, Hiroyuki　Inoue, Toshihisa Tsuruta, Kazunari Yamada, Mutsunori Murahashi, Takuya Tsunoda, Kenzaburo Tani. A phase I clinical study of a novel immunotherapy combined　chemotherapy in patients with advanced solid tumors. 第72回日本癌学会学術総会, 横浜, 2013
  58. Kyosuke Kobayashi, Koichi Kawahara, Akira Suzuki, Kenzaburo Tani, Atsushi Takahashi. Functions of FEAT tumor promoter in ES cells. 第72回日本癌学会学術総会, 横浜, 2013
  59. Yan Li, Kyosuke Kobayashi, Kenzaburo Tani, Atsushi Takahashi. Identification of proteins that interact with FEAT tumor promoter. 第72回日本癌学会学術総会, 横浜, 2013
  60. Hiroyuki Inoue, Ayumi Watanabe, Chika Sakamoto, Megumi Narusawa, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, and Kenzaburo Tani. Vaccination with irradiated induced pluripotent stem cells elicits substantial antitumor immunity. 第75回日本血液学会学術集会, 札幌, 2013
  61. Megumi Narusawa, Hiroyuki Inoue, Chika Sakamoto, Tomoko Inoue, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, Kenzaburo Tani. TLR7 ligand overcomes therapeutic resistance to GM-CSF-gene transduced tumor vaccination. 第75回日本血液学会学術集会, 札幌, 2013
  62. Takenobu Nii, Tomotoshi Marumoto, Saori Yamaguchi, Hirotaka Kawano, Jiyuan Liao, Yoko Nagai, Michiyo Okada, Yoshie Miura, Kenzaburo Tani: Efficient hematopoietic differentiation of common marmoset ES cells by inhibition of self-renewal. 第75回日本血液学会学術集会, 札幌, 2013
  63. Hiroyuki Inoue, Ayumi Watanabe, Chika Sakamoto, Megumi Narusawa, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Takafumi Hiramoto, Yoichi Nakanishi, and Kenzaburo Tani. Therapeutic iPS cell vaccination induces effective antitumor immunity in a syngeneic mouse model. 第54回日本肺癌学会総会, 東京, 2013
  64. Saori Yamaguchi, Tomotoshi Marumoto, Takenobu Nii, Hirotaka Kawano, Jiyuan Liao, Yoko Nagai, Michiyo Okada, Atsushi Takahashi, Hiroyuki Inoue, Erika Sasaki, Hiroshi Fujii, Shinji Okano, Yoshie Miura and Kenzaburo Tani. Characterization of dysgerminoma like tumors arisen in the process of generating common marmoset induced pluripotent stem cells. 第3回日本マーモセット研究会, 福岡, 2013
  65. Hirotaka Kawano, Tomotoshi Marumoto, Takafumi Hiramoto, Michiyo Okada, Takenobu Nii, Jiyuan Liao, Saori Yamaguchi, Hiroyuki Inoue, Erika Sasaki, Yoshie Kametani, Yoshie Miura, Kenzaburo Tani. LYL1, a basic helix-loop-helix transcription factor, induces hematopoietic stem cell from common marmoset embryonic stem cell. 第3回日本マーモセット研究会, 福岡, 2013
  66. Takenobu Nii, Tomotoshi Marumoto, Saori Yamaguchi, Hirotaka Kawano, Jiyuan Liao, Erika Sasaki and Kenzaburo Tani. Transient inhibition of PI3K-AKT pathway promotes hematopoietic differentiation in common marmoset embryonic stem cells. 第3回日本マーモセット研究会, 福岡, 2013
  67. Hiroyuki Inoue, Ayumi Watanabe, Chika Sakamoto, Megumi Narusawa, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Takafumi Hiramoto, Yoichi Nakanishi, and Kenzaburo Tani. A novel cell vaccination using irradiated induced pluripotent stem cells induces potent T cells-mediated antitumor immunity. 第11回日本免疫治療学研究会学術集会, 東京, 2013
  68. Chika Sakamoto, Hiroyuki Inoue, Megumi Narusawa, Yumiko Matsumura, Shohei Miyamoto, Makoto Inoue, Koichi Takayama, Mamoru Hasegawa, Yoichi Nakanishi, and Kenzaburo Tani. Therapeutic vaccination with GM-CSF gene-transduced breast cancer stem cells effectively suppress tumor growth and lung metastasis. 第11回日本免疫治療学研究会学術集会, 東京, 2013
  69. 土方 康基. 当科における難治性悪性腫瘍に対する免疫療法臨床試験の現状.第11回日本免疫治療学会研究会学術集会,東京, 2013
  70. Yasuki Hijikata, Toshihiko Okazaki, Yoshihiko Tanaka, Shinichi Kobayashi, Kazunari Yamada, Tomotoshi Marumoto, and Kenzaburo Tani. A phase Ⅰstudy of adoptive immunotherapy using autologous dendritic cell pulsed with a RNF43 peptide in patients with advanced solid tumors. 第5回造血器腫瘍免疫療法研究会,名古屋, 2013
  71. Yasuki Hijikata, Toshihiko Okazaki, Yoshihiko Tanaka, Shinichi Tanaka, Kazunari Yamada, and Kenzaburo Tani. A phase I clinical study of a novel immunotherapy for advanced solid tumors. 第51回日本癌治療学会学術集会,横浜, 2013
  72. 井上 博之, 王 倍倍, 中野友紀, 安成 啓佑, 宮本 将平, 高山 浩一, 中西 洋一, 谷 憲三朗. ヒトエンテロウイルスを用いた新規腫瘍溶解性ウイルス療法. 文部科学省［橋渡し研究加速ネットワークプログラム］TR推進合同フォーラム　－アカデミアの活力と実力を社会へ－, 福岡, 2013
  73. 小林 恭介, 李 妍, 河原 康一, 鈴木 聡, 谷 憲三朗, 高橋 淳.腫瘍促進タンパクFEATを用いた癌早期発見への応用. 文部科学省［橋渡し研究加速ネットワークプログラム］TR推進合同フォーラム　－アカデミアの活力と実力を社会へ－, 福岡, 2013